Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE3

Conditions

Type 1 Diabetes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Deparement of Endocrinology and Metabolism, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China
Contact: Study coordinator (Yong Gu) · yong.gu@njmu.edu.cn · +8613645148415

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Type 1 Diabetes Mellitus · T1D · T1DM

Abroad (travel likely)RecruitingPHASE1, PHASE2

Tucson, United States · Tucson, United States

Denosumab for Type 1 Diabetes

Type 1 Diabetes

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Duarte, United States

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

Type 1 Diabetes

Abroad (travel likely)RecruitingEARLY_PHASE1

Nashville, United States

Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease

Chronic Kidney Disease(CKD) · Type 1 Diabetes (T1D)

Abroad (travel likely)Recruiting

Cleveland, United States